EUVIMEDEUVIMED entdecken
Open Access

Suboptimal Levothyroxine Treatment is Associated with Increases in Mean Blood Pressure and Blood Pressure Variability

Matthew D Ettleson iD, Nikita Thomas, Wen Wan, Donald Hedeker, Anne R Cappola, Neda Laiteerapong iD, Antonio C Bianco

The Journal of Clinical Endocrinology & Metabolism · 19.05.2026 · 111 (6) · e1626-e1633

DOI: 10.1210/clinem/dgaf675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 17.12.2025. Verfasst von Matthew D Ettleson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Thyroxine, Blood Pressure, Hypothyroidism, Hypertension. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Diabetes Research and Training Center, Chicago Center for Diabetes Translation Research, Career Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Thyroid hormone homeostasis is critical to the metabolic function of cardiovascular tissues. The degree to which the suboptimal treatment of hypothyroidism with levothyroxine (LT4) impacts blood pressure (BP) and blood pressure variability (BPV) is not known.

Objectives

Determine the relationship between LT4 time above range (TAR) (TSH level >4.5 mIU/L), time below range (TBR) (TSH <0.4 mIU/L), and changes in annual mean systolic (SBP) and diastolic blood pressure (DBP) and visit-to-visit BPV.

Methods

Using longitudinal data from 2203 adult patients treated with LT4, we modeled within-individual changes in annual mean BP and BPV as a function of TAR and TBR (% time). Linear mixed-effect modeling was utilized to allow for differences in observation time between patients. Models were adjusted for sociodemographics, baseline comorbidities, weight, LT4 dose, time, and year of study enrollment. Sensitivity analyses were conducted with wide in-range boundaries (TSH 0.1-10 mIU/L) and stratification by hypertension at baseline.

Results

In the primary modeling, a 100% increase in TAR was associated with significant increases in annual mean SBP and DBP (+1.8 mmHg, P = .011; +1.0 mmHg, P = .024, respectively). Similarly, a 100% increase in TBR was associated with increases in annual mean SBP and DBP (+2.7 mmHg, P = .004; +1.3 mmHg, P = .034, respectively). However, the expected differences in BP with TAR and TBR diminished in subsequent years. One hundred percent TAR and TBR were associated with small increases in annual visit-to-visit diastolic BPV (+0.67 mmHg, P = .009; +0.85 mmHg, P = .020, respectively).

Conclusion

Suboptimal LT4 treatment was associated with increases in mean BP and BPV, representing potential mediators in the pathway between suboptimal LT4 treatment and cardiovascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThyroxineBlood PressureHypothyroidismHypertensionHormone Replacement TherapyHumansMaleFemaleMiddle AgedLongitudinal StudiesAdultAgedThyrotropin

Stichwörter der Autor:innen

blood pressure variabilitycardiovascular riskhypothyroidismlevothyroxine

Substanzen

ThyroxineThyrotropin

Autor:innen und Institutionen

  • Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL 60637, USA.
  • Section of General Internal Medicine, University of Chicago, Chicago, IL 60637, USA.
  • Department of Public Health Sciences, University of Chicago, Chicago, IL 60637, USA.
  • Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Division of Endocrinology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.

ORCID-Profile: Matthew D Ettleson, Neda Laiteerapong

Förderung

  • Diabetes Research and Training Center
  • Chicago Center for Diabetes Translation Research
  • Career Development Program
  • NIA NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Disease
  • NIDDK NIH HHS
  • NIH HHS
  • University of Chicago

Zitieren

APA

Ettleson, M. D., Thomas, N., Wan, W., Hedeker, D., Cappola, A. R., Laiteerapong, N., & Bianco, A. C. (2026). Suboptimal Levothyroxine Treatment is Associated with Increases in Mean Blood Pressure and Blood Pressure Variability. The Journal of Clinical Endocrinology & Metabolism, 111(6), e1626-e1633. https://doi.org/10.1210/clinem/dgaf675

Vancouver

Ettleson MD, Thomas N, Wan W, Hedeker D, Cappola AR, Laiteerapong N, et al. Suboptimal Levothyroxine Treatment is Associated with Increases in Mean Blood Pressure and Blood Pressure Variability. The Journal of Clinical Endocrinology & Metabolism. 2026;111(6):e1626-e1633. doi:10.1210/clinem/dgaf675

BibTeX
@article{Ettleson2026,
  author = {Ettleson, Matthew D and Thomas, Nikita and Wan, Wen and Hedeker, Donald and Cappola, Anne R and Laiteerapong, Neda and Bianco, Antonio C},
  title = {Suboptimal Levothyroxine Treatment is Associated with Increases in Mean Blood Pressure and Blood Pressure Variability},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  volume = {111},
  number = {6},
  pages = {e1626--e1633},
  doi = {10.1210/clinem/dgaf675}
}
Kostenlos starten →